Solid Tumors Harboring NTRK Fusion Active Not Recruiting Phase 1 / 2 Trials for Larotrectinib (DB14723)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

IndicationStatusPhase
DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02637687A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenTreatment